Jupiter Life Line Hospitals Limited (JLHL) - Net Assets
Based on the latest financial reports, Jupiter Life Line Hospitals Limited (JLHL) has net assets worth Rs15.44 Billion INR (≈ $166.99 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs23.83 Billion ≈ $257.73 Million USD) and total liabilities (Rs8.39 Billion ≈ $90.74 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See JLHL net asset quality score to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs15.44 Billion |
| % of Total Assets | 64.79% |
| Annual Growth Rate | 36.7% |
| 5-Year Change | 435.34% |
| 10-Year Change | N/A |
| Growth Volatility | 76.94 |
Jupiter Life Line Hospitals Limited - Net Assets Trend (2020–2026)
This chart illustrates how Jupiter Life Line Hospitals Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market value of Jupiter Life Line Hospitals Limited.
Annual Net Assets for Jupiter Life Line Hospitals Limited (2020–2026)
The table below shows the annual net assets of Jupiter Life Line Hospitals Limited from 2020 to 2026. Also explore Jupiter Life Line Hospitals Limited annual equity growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs15.44 Billion ≈ $166.99 Million |
+13.85% |
| 2025-03-31 | Rs13.56 Billion ≈ $146.67 Million |
+16.04% |
| 2024-03-31 | Rs11.69 Billion ≈ $126.39 Million |
+221.16% |
| 2023-03-31 | Rs3.64 Billion ≈ $39.36 Million |
+26.17% |
| 2022-03-31 | Rs2.88 Billion ≈ $31.19 Million |
+17.04% |
| 2021-03-31 | Rs2.46 Billion ≈ $26.65 Million |
+4.10% |
| 2020-03-31 | Rs2.37 Billion ≈ $25.60 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Jupiter Life Line Hospitals Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 372.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs7.35 Billion | 47.59% |
| Common Stock | Rs655.66 Million | 4.25% |
| Other Components | Rs7.44 Billion | 48.16% |
| Total Equity | Rs15.44 Billion | 100.00% |
Jupiter Life Line Hospitals Limited Competitors by Market Cap
The table below lists competitors of Jupiter Life Line Hospitals Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Esquire Financial Holdings Inc
NASDAQ:ESQ
|
$992.97 Million |
|
PT Super Bank Indonesia Tbk
JK:SUPA
|
$993.12 Million |
|
Yotrio Group Co Ltd
SHE:002489
|
$993.45 Million |
|
CBL & Associates Properties Inc
NYSE:CBL
|
$993.50 Million |
|
Bravura Solutions Ltd
AU:BVS
|
$992.84 Million |
|
BrightView Holdings
NYSE:BV
|
$992.58 Million |
|
Lindab International AB
ST:LIAB
|
$992.35 Million |
|
Matrix Design Co. Ltd. A
SHE:301365
|
$992.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Jupiter Life Line Hospitals Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 13,562,420,000 to 15,440,840,000, a change of 1,878,420,000 (13.9%).
- Net income of 1,941,870,000 contributed positively to equity growth.
- Dividend payments of 65,569,999 reduced retained earnings.
- Other comprehensive income decreased equity by 743,570,000.
- Other factors increased equity by 745,689,999.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs1.94 Billion | +12.58% |
| Dividends Paid | Rs65.57 Million | -0.42% |
| Other Comprehensive Income | Rs-743.57 Million | -4.82% |
| Other Changes | Rs745.69 Million | +4.83% |
| Total Change | Rs- | 13.85% |
Book Value vs Market Value Analysis
This analysis compares Jupiter Life Line Hospitals Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.95x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 33.43x to 5.95x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-03-31 | Rs8.38 | Rs280.05 | x |
| 2021-03-31 | Rs7.29 | Rs280.05 | x |
| 2022-03-31 | Rs8.95 | Rs280.05 | x |
| 2023-03-31 | Rs11.15 | Rs280.05 | x |
| 2024-03-31 | Rs37.97 | Rs280.05 | x |
| 2025-03-31 | Rs41.38 | Rs280.05 | x |
| 2026-03-31 | Rs47.06 | Rs280.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Jupiter Life Line Hospitals Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.58%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.95%
- • Asset Turnover: 0.63x
- • Equity Multiplier: 1.54x
- Recent ROE (12.58%) is below the historical average (12.98%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 12.52% | 6.40% | 0.77x | 2.55x | Rs59.59 Million |
| 2021 | -0.96% | -0.47% | 0.62x | 3.30x | Rs-261.95 Million |
| 2022 | 17.42% | 6.97% | 0.81x | 3.10x | Rs217.73 Million |
| 2023 | 19.94% | 8.17% | 0.91x | 2.70x | Rs363.37 Million |
| 2024 | 15.11% | 16.51% | 0.83x | 1.10x | Rs597.08 Million |
| 2025 | 14.25% | 15.31% | 0.66x | 1.40x | Rs575.73 Million |
| 2026 | 12.58% | 12.95% | 0.63x | 1.54x | Rs397.79 Million |
Industry Comparison
This section compares Jupiter Life Line Hospitals Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $24,415,447,556
- Average return on equity (ROE) among peers: 12.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Jupiter Life Line Hospitals Limited (JLHL) | Rs15.44 Billion | 12.52% | 0.54x | $992.88 Million |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $58.78 Billion | 17.96% | 1.24x | $13.91 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $22.51 Billion | 4.52% | 2.02x | $4.22 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $1.16 Billion | 12.91% | 1.22x | $147.49 Million |
| Healthcare Global Enterprises Limited (HCG) | $5.79 Billion | 3.54% | 1.49x | $1.14 Billion |
| Krishna Institute of Medical Sciences Limited (KIMS) | $3.34 Billion | 9.75% | 1.32x | $3.50 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $151.10 Million | 8.52% | 0.57x | $25.89 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $107.47 Billion | 13.42% | 0.60x | $11.04 Billion |
| Max India Limited (MAXIND) | $7.06 Billion | 36.09% | 0.45x | $93.00 Million |
| Global Health Limited (MEDANTA) | $13.50 Billion | 2.69% | 0.98x | $4.36 Billion |
About Jupiter Life Line Hospitals Limited
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT,… Read more